OcyonBio Appoints Robert Salcedo as Chief Executive Officer
Jan 6, 2022
Robert Salcedo
CEO and co-Founder of OcyonBio, the most comprehensive advanced therapy PDMO partner in the industry servicing pre-clinical to commercial phase therapies
OcyonBio, LLC is creating cell and gene therapy partnership development and manufacturing organization (PDMO). OcyonBio will provide preclinical through commercial manufacturing, including process development, viral vectors, cell banking, cell processing, and supporting testing capabilities.
The 100,000+ square-foot facility also has full cGMP clean rooms to support incubator space for pre-clinical and clinical phased companies. Facilities are located in Puerto Rico, a U.S. pharmaceutical center of excellence and financial advantages that can reduce the cost of research and development by more than 50%.
Robert Salcedo has 25+ years of experience in Biotechnology and Solid Dose Manufacturing experience, which includes 7+ years of working closely with start-ups in gene and cell therapy companies. He led executive teams in Developing Regulatory, CMC, Clinical, and manufacturing scale-up strategies and constructing commercial facilities ranging from $20MM to $1.5Bn. He was a leader in Amgen's construction and technology transfer in Puerto Rico, which supplies drug products to the world. He previously consulted and advised 50+ clients focused on both gene and cell therapy and biologics companies.
"I am thrilled to lead OcyonBio. We are developing a Partnership Development Organization model, which, combined with the tax incentives offered by Puerto Rico, makes our approach truly best in class. I am laser-focused on building a company that will solve the biggest challenge in cell and gene therapy development, which is high-quality manufacturing," said Robert Salcedo. "Beyond manufacturing, our goals include the creation of high-performing teams and fostering an exciting and inspiring culture with a close connection to the patients and customers we ultimately serve," he added.
Puerto Rico has long been a major center for pharmaceutical and medical device manufacturing. According to the FDA, 8% of pharmaceutical expenditures by Americans are for products manufactured in Puerto Rico. There is a well-developed ecosystem of highly skilled employees who have the technical skills needed to work in a highly regulated and safety-oriented operating environment. Puerto Rico is also entirely within the customs territory of the United States, and manufacturing is subject to FDA and other federal agency oversight.
About OcyonBio, LLC
OcyonBio is the most comprehensive advanced therapy PDMO partner in the industry, servicing pre-clinical to commercial phase therapies, following a molecule from idea to launch, and providing a full spectrum of services all in one location. This horizontal integration enables the utmost quality and accelerates time to market with single-source, end-to-end solutions.
CONTACT
Name: Daniel Mora
Phone: 1-646-480-0356
Email: [email protected]
Press Release Service by Newswire.com
Original Source: OcyonBio Appoints Robert Salcedo as Chief Executive Officer
More News
Binance Lost Over $6 Billion in Crypto Hack. Here’s What to Know.
Hackers made off with around $6 billion in digital currency in what could be the biggest crypto heist in history. Binance said it will cover the losses.
Soaring cost of Halloween treats spooks shoppers
The price of candy, especially chocolate, is up, and Halloween bargain hunters are searching for deals and ways to cut costs.
Binance’s $6.3 Billion Hack Is Just the Start of a Risky New Era
The largest cyber heist in history came as attackers increasingly use artificial intelligence and other advanced techniques to steal crypto and quickly launder the funds.
Crypto giant Binance attempting to recover $6.3bn stolen in hack linked to North Korea
The cyber-attack, which the company describes as complex, is believed to be the largest ever of its kind.
Binance Was Hacked. What Protections Exist for Crypto Customers?
After a $6.3 billion hack, the company said it was going to reimburse customers who had losses.
Tech Stocks See Worst Day Since June, Pressuring Broader Market
The Nasdaq and the S&P 500 had their worst day since June as investors worried about spending on A.I. infrastructure.
US tech stocks see sharp falls as AI spending nears $1tn
Shares in Intel continue to fall while the tech-heavy Nasdaq opens at its lowest level in more than two months.
Lawsuit Accuses Education Dept. of Throttling Debt Cancellation Through PSLF Program
Public servants on the brink of student debt forgiveness are facing setbacks and extensive delays. The American Federation of Teachers sued to help them.
The Tech Tumult Rocks Wall Street
Investors are growing nervous about the huge spending bills that tech giants are amassing to pay for their bets on artificial intelligence.
Why Kalshi Wants to Repeal a 1958 Law About Onions
A law enacted after a brazen scheme to rig onion prices in the 1950s puts the vegetable, as well as box office receipts, off-limits for prediction markets.
Binance Hack Sends Crypto Stocks Tumbling
The rout hit publicly traded crypto exchanges and fintech companies, as well as cryptocurrencies like Bitcoin.
Meta Settles Social Media Addiction Case, Avoiding Trial
The case, brought by an 18-year-old Mississippi woman and set for trial next week, was the fourth of nine bellwether personal injury lawsuits.
YOUR NEWS, OUR NETWORK.
Do you have Great News you want to tell the world?
Be it updates about your business or your community, you can make sure that it’s heard by submitting your story to our network reaching hundreds of news sites across 6 verticals.